Cargando…
Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906452/ https://www.ncbi.nlm.nih.gov/pubmed/35284802 http://dx.doi.org/10.1097/HS9.0000000000000692 |
| _version_ | 1784665405530308608 |
|---|---|
| author | Kutsch, Nadine Pallasch, Christian Tausch, Eugen Böhme, Volkmar Ritgen, Matthias Liersch, Rüdiger Wacker, Alexander Jacobs, Georg Trappe, Ralf Ulrich Dreger, Peter Fischer, Kirsten Fink, Anna-Maria Stilgenbauer, Stephan Zhai, Shuyan Li, Biao Jürgensmeier, Juliane M. Rajakumaraswamy, Nishanthan Bhargava, Pankaj Hallek, Michael Eichhorst, Barbara F. |
| author_facet | Kutsch, Nadine Pallasch, Christian Tausch, Eugen Böhme, Volkmar Ritgen, Matthias Liersch, Rüdiger Wacker, Alexander Jacobs, Georg Trappe, Ralf Ulrich Dreger, Peter Fischer, Kirsten Fink, Anna-Maria Stilgenbauer, Stephan Zhai, Shuyan Li, Biao Jürgensmeier, Juliane M. Rajakumaraswamy, Nishanthan Bhargava, Pankaj Hallek, Michael Eichhorst, Barbara F. |
| author_sort | Kutsch, Nadine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8906452 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89064522022-03-10 Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia Kutsch, Nadine Pallasch, Christian Tausch, Eugen Böhme, Volkmar Ritgen, Matthias Liersch, Rüdiger Wacker, Alexander Jacobs, Georg Trappe, Ralf Ulrich Dreger, Peter Fischer, Kirsten Fink, Anna-Maria Stilgenbauer, Stephan Zhai, Shuyan Li, Biao Jürgensmeier, Juliane M. Rajakumaraswamy, Nishanthan Bhargava, Pankaj Hallek, Michael Eichhorst, Barbara F. Hemasphere Letter Lippincott Williams & Wilkins 2022-03-08 /pmc/articles/PMC8906452/ /pubmed/35284802 http://dx.doi.org/10.1097/HS9.0000000000000692 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
| spellingShingle | Letter Kutsch, Nadine Pallasch, Christian Tausch, Eugen Böhme, Volkmar Ritgen, Matthias Liersch, Rüdiger Wacker, Alexander Jacobs, Georg Trappe, Ralf Ulrich Dreger, Peter Fischer, Kirsten Fink, Anna-Maria Stilgenbauer, Stephan Zhai, Shuyan Li, Biao Jürgensmeier, Juliane M. Rajakumaraswamy, Nishanthan Bhargava, Pankaj Hallek, Michael Eichhorst, Barbara F. Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia |
| title | Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia |
| title_full | Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia |
| title_fullStr | Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia |
| title_full_unstemmed | Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia |
| title_short | Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia |
| title_sort | efficacy and safety of the combination of tirabrutinib and entospletinib with or without obinutuzumab in relapsed chronic lymphocytic leukemia |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906452/ https://www.ncbi.nlm.nih.gov/pubmed/35284802 http://dx.doi.org/10.1097/HS9.0000000000000692 |
| work_keys_str_mv | AT kutschnadine efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT pallaschchristian efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT tauscheugen efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT bohmevolkmar efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT ritgenmatthias efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT lierschrudiger efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT wackeralexander efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT jacobsgeorg efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT trapperalfulrich efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT dregerpeter efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT fischerkirsten efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT finkannamaria efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT stilgenbauerstephan efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT zhaishuyan efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT libiao efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT jurgensmeierjulianem efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT rajakumaraswamynishanthan efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT bhargavapankaj efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT hallekmichael efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia AT eichhorstbarbaraf efficacyandsafetyofthecombinationoftirabrutinibandentospletinibwithorwithoutobinutuzumabinrelapsedchroniclymphocyticleukemia |